About Dr. Chen Shengliang
Dr. Chen Shengliang (陈胜良) is a Professor, Doctoral Supervisor, and one of China's leading gastroenterologists specializing in functional gastrointestinal disorders, motility disorders, and the gut-brain axis, based at the Department of Gastroenterology, Renji Hospital, Shanghai Jiao Tong University School of Medicine. With extensive clinical and research expertise in the diagnosis and management of irritable bowel syndrome (IBS), functional dyspepsia, gastroparesis, gastroesophageal reflux disease (GERD), esophageal motility disorders, and other disorders of gut-brain interaction (DGBIs), Dr. Chen is recognized as a senior authority in neurogastroenterology and motility at one of China's most distinguished academic medical centers.
Functional gastrointestinal disorders — now more precisely termed disorders of gut-brain interaction (DGBIs) — are among the most prevalent conditions in gastroenterology, affecting up to 40% of the global population and accounting for a substantial proportion of gastroenterology outpatient consultations worldwide. Despite their prevalence, these conditions are frequently misdiagnosed, inadequately investigated, and suboptimally managed in general practice settings, leading to years of unnecessary suffering, repeated investigations, and ineffective treatments. The optimal management of DGBIs requires a specialist who understands the complex interplay between gut motility, visceral hypersensitivity, the gut microbiome, psychological factors, and central nervous system processing — and who can design an individualized, evidence-based management strategy that addresses all relevant contributing factors. Dr. Chen's clinical practice at Renji Hospital provides international patients with access to this level of specialist neurogastroenterology expertise, which is rarely available outside major academic gastroenterology centers.
Hospital Affiliation: Department of Gastroenterology, Renji Hospital
Renji Hospital (仁济医院), affiliated with Shanghai Jiao Tong University School of Medicine, is one of Shanghai's largest and most prestigious academic medical centers. Its Department of Gastroenterology is one of the highest-volume and most academically productive gastroenterology programs in China. The department's motility laboratory provides comprehensive gastrointestinal motility testing including high-resolution esophageal manometry (HRM) with Chicago Classification v4.0 interpretation, ambulatory 24-hour pH-impedance monitoring for GERD and non-acid reflux assessment, gastric emptying scintigraphy for gastroparesis diagnosis, anorectal manometry for defecatory disorders, and wireless motility capsule for whole-gut transit assessment. Its gut microbiome research program — one of the most active in China — investigates the role of the gut microbiome in IBS, functional dyspepsia, and other DGBIs, and evaluates microbiome-targeted therapies including fecal microbiota transplantation (FMT) in clinical trials.
Clinical Specialties: What Dr. Chen Shengliang Treats
- Irritable bowel syndrome (IBS) — diagnosis using Rome IV criteria with exclusion of organic pathology; IBS subtype characterization (IBS-C, IBS-D, IBS-M, IBS-U); dietary management including low-FODMAP diet with dietitian coordination; gut-directed pharmacotherapy including antispasmodics, loperamide, linaclotide, lubiprostone, rifaximin for IBS-D, and tricyclic antidepressants and SNRIs for visceral hypersensitivity; gut-directed psychotherapy including cognitive behavioral therapy (CBT) and gut-directed hypnotherapy coordination; fecal microbiota transplantation (FMT) for post-infectious IBS in clinical trial settings; management of IBS with comorbid anxiety and depression
- Functional dyspepsia — diagnosis using Rome IV criteria (epigastric pain syndrome and postprandial distress syndrome subtypes); H. pylori testing and eradication for H. pylori-positive functional dyspepsia; prokinetic therapy with domperidone, mosapride, and acotiamide; acid suppression with PPIs for epigastric pain syndrome; low-dose tricyclic antidepressants for refractory functional dyspepsia; dietary modification and eating behavior counseling
- Gastroesophageal reflux disease (GERD) and esophageal motility disorders — GERD diagnosis with 24-hour pH-impedance monitoring; PPI therapy optimization; laparoscopic fundoplication coordination for PPI-refractory GERD; high-resolution esophageal manometry with Chicago Classification v4.0 for esophageal motility disorder diagnosis including achalasia, esophagogastric junction outflow obstruction, absent contractility, distal esophageal spasm, and hypercontractile esophagus; pneumatic dilation and per-oral endoscopic myotomy (POEM) coordination for achalasia; non-cardiac chest pain evaluation and management
- Gastroparesis and gastric motility disorders — gastroparesis diagnosis with gastric emptying scintigraphy; dietary modification for gastroparesis; prokinetic therapy with metoclopramide, domperidone, and erythromycin; gastric electrical stimulation coordination for refractory gastroparesis; management of diabetic gastroparesis with coordination with endocrinology; cyclic vomiting syndrome diagnosis and management
- Chronic constipation and defecatory disorders — evaluation of chronic constipation including colonic transit study, anorectal manometry, and balloon expulsion test; slow transit constipation management with osmotic and stimulant laxatives, prucalopride, and linaclotide; dyssynergic defecation diagnosis and biofeedback therapy; pelvic floor dysfunction coordination with colorectal surgery and pelvic floor physiotherapy
- Fecal microbiota transplantation (FMT) — FMT for recurrent Clostridioides difficile infection; FMT evaluation for IBS, functional constipation, and other microbiome-associated conditions in clinical trial settings; gut microbiome profiling and microbiome-targeted dietary interventions
- Gut-brain axis and psychological comorbidity management — assessment of psychological comorbidities (anxiety, depression, somatization) in patients with DGBIs; neuromodulator therapy with low-dose tricyclic antidepressants, SNRIs, and mirtazapine for visceral hypersensitivity and central sensitization; coordination with psychiatry and clinical psychology for gut-directed psychotherapy; mindfulness-based stress reduction (MBSR) for DGBIs
Why International Patients Choose Dr. Chen Shengliang and Renji Hospital
International patients — particularly expatriates living in Shanghai who have struggled for years with IBS, functional dyspepsia, GERD, or other functional gastrointestinal conditions without achieving satisfactory diagnosis or symptom control — seek consultation with Dr. Chen Shengliang for a level of specialist neurogastroenterology expertise that is rarely available outside major academic gastroenterology centers.
For patients with longstanding IBS or functional dyspepsia who have been told that their investigations are normal and that nothing more can be done, Dr. Chen's systematic approach to DGBI diagnosis and management — including precise Rome IV subtyping, comprehensive motility testing, dietary assessment, and individualized pharmacological and psychological treatment strategies — frequently identifies a more nuanced diagnosis and a more effective management approach than has been previously offered. The availability of comprehensive motility testing — including high-resolution esophageal manometry, 24-hour pH-impedance monitoring, and gastric emptying scintigraphy — at Renji Hospital enables the precise physiological characterization of gastrointestinal symptoms that is the foundation of optimal DGBI management.
For patients with esophageal motility disorders — including achalasia, esophagogastric junction outflow obstruction, and hypercontractile esophagus — Dr. Chen's expertise in high-resolution manometry interpretation and his coordination with the endoscopy team for POEM provides access to the most advanced esophageal motility diagnosis and treatment available in China. The cost of gastroenterology consultation and motility testing at Renji Hospital is substantially below that of equivalent care in Western healthcare systems, and access to specialist consultation can typically be arranged within days through CMCS.
What to Expect at Your Consultation
Consultations with Dr. Chen Shengliang at Renji Hospital arranged through CMCS begin with a comprehensive review of all prior gastrointestinal records — including prior endoscopy reports, motility testing results, imaging, laboratory investigations, prior dietary assessments, and current and prior medication history — as well as a detailed gastrointestinal symptom history including symptom onset, pattern, triggers, and impact on quality of life. CMCS will arrange certified translation of all medical records and investigation results in advance of the consultation. Dr. Chen will assess the gastrointestinal symptom pattern, evaluate the diagnostic workup and identify any gaps, outline the recommended diagnostic and therapeutic strategy, and coordinate motility testing, dietary assessment, and psychological support where indicated. A written English-language consultation summary is provided after every appointment, and CMCS will facilitate direct communication between Dr. Chen's team and the patient's home gastroenterologist for continuity of care planning.
Book a Consultation Through CMCS
China Medical Concierge Shanghai (CMCS) provides comprehensive end-to-end support for international patients seeking gastroenterology and functional GI consultation with Dr. Chen Shengliang at Renji Hospital. Our services include priority consultation scheduling, certified medical record translation, coordination of motility testing and endoscopy, on-site interpretation, and written English-language reporting of all findings and recommendations.
📧 contract@medicalsh.com | 💬 WeChat: gezhanglao | 🌐 medicalsh.com
0 comentarios